Nivolumab induced encephalopathy in a man with metastatic renal cell cancer: a case report
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1752-1947
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Nivolumab induced encephalopathy in a man with metastatic renal cell cancer: a case report ; volume:12 ; number:1 ; day:15 ; month:9 ; year:2018 ; pages:1-8 ; date:12.2018
Journal of medical case reports ; 12, Heft 1 (15.9.2018), 1-8, 12.2018
- Urheber
-
Kopecký, Jindřich
- Beteiligte Personen und Organisationen
-
Kubeček, Ondřej
Geryk, Tomáš
Slováčková, Birgita
Hoffmann, Petr
Žiaran, Miroslav
Priester, Peter
SpringerLink (Online service)
- DOI
-
10.1186/s13256-018-1786-9
- URN
-
urn:nbn:de:101:1-2018102023390950309993
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:37 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kopecký, Jindřich
- Kubeček, Ondřej
- Geryk, Tomáš
- Slováčková, Birgita
- Hoffmann, Petr
- Žiaran, Miroslav
- Priester, Peter
- SpringerLink (Online service)
Ähnliche Objekte (12)
Immune-Related Meningoencephalitis following Nivolumab in Metastatic Renal Cell Carcinoma
Pazopanib after Nivolumab-Induced Tumor Lysis Syndrome in a Patient with Metastatic Clear-Cell Renal Cell Carcinoma
Nivolumab Induced Lethal Aplastic Anemia in a Patient with Metastatic Melanoma
Immunomodulatory response to neoadjuvant nivolumab in non-metastatic clear cell renal cell carcinoma
Nivolumab induced myxedema crisis
Nivolumab for Metastatic Cutaneous Squamous Cell Carcinoma
Metastatic Merkel cell carcinoma response to nivolumab
Pre-treatment metastatic growth rate is associated with clinical outcome in patients with metastatic renal cell carcinoma treated with nivolumab
Prognostic impact of FAN score in patients receiving nivolumab plus ipilimumab for metastatic renal cell carcinoma
Visceral Leishmaniasis in a 62-Year-Old Woman with Metastatic Renal Cancer in Treatment with Nivolumab
Significant response to nivolumab for metastatic chromophobe renal cell carcinoma with sarcomatoid differentiation: a case report
Nivolumab-Induced Exocrine Pancreatic Insufficiency
Immune-Related Meningoencephalitis following Nivolumab in Metastatic Renal Cell Carcinoma
Pazopanib after Nivolumab-Induced Tumor Lysis Syndrome in a Patient with Metastatic Clear-Cell Renal Cell Carcinoma
Nivolumab Induced Lethal Aplastic Anemia in a Patient with Metastatic Melanoma
Immunomodulatory response to neoadjuvant nivolumab in non-metastatic clear cell renal cell carcinoma
Nivolumab induced myxedema crisis
Nivolumab for Metastatic Cutaneous Squamous Cell Carcinoma
Metastatic Merkel cell carcinoma response to nivolumab
Pre-treatment metastatic growth rate is associated with clinical outcome in patients with metastatic renal cell carcinoma treated with nivolumab
Prognostic impact of FAN score in patients receiving nivolumab plus ipilimumab for metastatic renal cell carcinoma
Visceral Leishmaniasis in a 62-Year-Old Woman with Metastatic Renal Cancer in Treatment with Nivolumab
Significant response to nivolumab for metastatic chromophobe renal cell carcinoma with sarcomatoid differentiation: a case report
Nivolumab-Induced Exocrine Pancreatic Insufficiency
Immune-Related Meningoencephalitis following Nivolumab in Metastatic Renal Cell Carcinoma
Pazopanib after Nivolumab-Induced Tumor Lysis Syndrome in a Patient with Metastatic Clear-Cell Renal Cell Carcinoma
Nivolumab Induced Lethal Aplastic Anemia in a Patient with Metastatic Melanoma
Immunomodulatory response to neoadjuvant nivolumab in non-metastatic clear cell renal cell carcinoma
Nivolumab induced myxedema crisis
Nivolumab for Metastatic Cutaneous Squamous Cell Carcinoma
Metastatic Merkel cell carcinoma response to nivolumab
Pre-treatment metastatic growth rate is associated with clinical outcome in patients with metastatic renal cell carcinoma treated with nivolumab
Prognostic impact of FAN score in patients receiving nivolumab plus ipilimumab for metastatic renal cell carcinoma
Visceral Leishmaniasis in a 62-Year-Old Woman with Metastatic Renal Cancer in Treatment with Nivolumab
Significant response to nivolumab for metastatic chromophobe renal cell carcinoma with sarcomatoid differentiation: a case report